- Report
- March 2024
- 148 Pages
Global
From €3741EUR$3,899USD£3,222GBP
- Report
- February 2024
- 114 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Report
- August 2023
- 145 Pages
Global
From €3022EUR$3,150USD£2,603GBP
- Report
- November 2023
- 30 Pages
United States
From €2639EUR$2,750USD£2,273GBP
- Report
- March 2023
- 100 Pages
Global
From €2639EUR$2,750USD£2,273GBP
- Report
- March 2021
- 149 Pages
Global
From €6668EUR$6,950USD£5,744GBP
- Report
- September 2022
- 392 Pages
Global
From €3454EUR$3,600USD£2,975GBP
Loteprednol is a topical corticosteroid used to treat a variety of ocular disorders, including allergic conjunctivitis, vernal keratoconjunctivitis, and post-operative inflammation. It is available in both ophthalmic suspension and ointment forms. Loteprednol is a synthetic corticosteroid that works by reducing inflammation and suppressing the immune system. It is used to reduce the symptoms of eye inflammation, such as redness, itching, and swelling.
Loteprednol is a popular choice for treating ocular disorders due to its low risk of side effects and its ability to reduce inflammation quickly. It is also used to treat dry eye syndrome, a condition that can cause discomfort and blurred vision. Loteprednol is available in both generic and brand-name forms.
The Loteprednol market is a competitive one, with many companies offering products for the treatment of ocular disorders. Some of the companies in the market include Allergan, Bausch + Lomb, Merck, Novartis, and Pfizer. Show Less Read more